Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTC:HKMPF
- CUSIP: N/A
- Web: N/A
- Market Cap: $6.11 billion
- Outstanding Shares: 240,959,000
- 50 Day Moving Avg: $24.72
- 200 Day Moving Avg: $23.85
- 52 Week Range: $20.43 - $35.25
Sales & Book Value:
- Trailing P/E Ratio: 38.29
- Foreward P/E Ratio: 14.08
- P/E Growth: 0.00
- Annual Revenue: $1.95 billion
- Price / Sales: 3.13
- Book Value: $9.94 per share
- Price / Book: 2.55
Frequently Asked Questions for Hikma Pharmaceutic (OTC:HKMPF)
What is Hikma Pharmaceutic's stock symbol?
Hikma Pharmaceutic trades on the OTC under the ticker symbol "HKMPF."
Who are some of Hikma Pharmaceutic's key competitors?
Some companies that are related to Hikma Pharmaceutic include Land Securities Gp (LSGOF), UNICREDIT SPA NPV (POST REV SPLIT) (UNCFF), Standard Life (SLFPF), MGM China Holdings (MCHVF), RSA Insurance Group plc (RSNAY), Scor Se (SCRYY), Mtu Aero Engines A (MTUAY), ENAGAS SA EUR1.50 (ENGGF), Just Eat Plc (JSTLF), Rightmove (RTMVY), Man Group Plc (MNGPF), Tullow Oil (TUWLF), Petrofac (POFCF), Spirent Communications Plc (SPMYY), Debenhams PLC (DBHSY), Contura Energy (CNTE), Saipem SpA (SAPMY) and Power Solutions International (PSIX).
How do I buy Hikma Pharmaceutic stock?
Shares of Hikma Pharmaceutic can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Hikma Pharmaceutic's stock price today?
MarketBeat Community Rating for Hikma Pharmaceutic (OTC HKMPF)MarketBeat's community ratings are surveys of what our community members think about Hikma Pharmaceutic and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Hikma Pharmaceutic stock can currently be purchased for approximately $25.35.
Earnings History for Hikma Pharmaceutic (OTC:HKMPF)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Hikma Pharmaceutic (OTC:HKMPF)
Current Year EPS Consensus Estimate: $1.39 EPS
Next Year EPS Consensus Estimate: $1.80 EPS
Dividend History for Hikma Pharmaceutic (OTC:HKMPF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Hikma Pharmaceutic (OTC:HKMPF)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Hikma Pharmaceutic (OTC:HKMPF)
Latest Headlines for Hikma Pharmaceutic (OTC:HKMPF)